Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: Results of a surgical prospective clinical practice protocol

Cancer

Volumn 104, Issue 4, 2005, Pages 692-699

  Raut, Chandrajit P ^a,c   Hunt, Kelly K ^a   Akins, Jeri S ^a   Daley, M Denise ^a   Ross, Merrick I ^a   Singletary, S Eva ^a   Marshall Jr , Gailen D ^b   Meric Bernstam, Funda ^a   Babiera, Gildy ^a   Feig, Barry W ^a   Ames, Frederick C ^a   Kuerer, Henry M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anaphylactoid reaction; Breast carcinoma; Isosulfan blue dye; Prophylaxis; Sentinel lymph node

Indexed keywords

ADRENALIN; AMOXICILLIN; CEFAZOLIN; CIPROFLOXACIN; CLINDAMYCIN; CODEINE; DEXAMETHASONE; DIPHENHYDRAMINE; FAMOTIDINE; FLUCONAZOLE; FLUOCINONIDE; GLUCOCORTICOID; HYDROCORTISONE; HYDROXYZINE; HYPERTENSIVE AGENT; ISOSULFAN BLUE; METHYLPREDNISOLONE; MIDAZOLAM; ONDANSETRON; PARACETAMOL; PENICILLIN G; PSEUDOMONIC ACID; RANITIDINE; ROCURONIUM; SALBUTAMOL; SUFENTANIL; SULFUR; TECHNETIUM 99M; TRIAMCINOLONE; UNINDEXED DRUG;

ADULT; AGED; ANAPHYLAXIS; ANESTHESIA INDUCTION; ARTICLE; ASSISTED VENTILATION; BREAST CARCINOMA; CANCER PREVENTION; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG ADMINISTRATION ROUTE; FACE EDEMA; FEMALE; HUMAN; HYPOTENSION; INTENSIVE CARE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PERITUMORAL DRUG ADMINISTRATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROPHYLAXIS; RASH; URTICARIA;

AGED; ANAPHYLAXIS; BREAST NEOPLASMS; CLINICAL PROTOCOLS; FEMALE; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; INCIDENCE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 23444457720     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21226     Document Type: Article

References (35)

1. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg. 1986;73:580-584.
2. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 1986;12:1575-1582.
3. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001;182:393-398.
4. Cimmino VM, Brown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy-a common event. Surgery. 2001;130:439-442.
5. Hirsch JI, Tisnado J, Cho SR, Beachley MC. Use of isosulfan blue for identification of lymphatic vessels: experimental and clinical evaluation. AJR Am J Roentgenol. 1982;139:1061-1064.
6. Leong SP, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000;7:361-366.
7. Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg. 2002;95:385-388.
8. Raut CP, Daley MD, Hunt KK, et al. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol. 2004;22:567-568.
9. Gueant JL, Aimone-Gastin I, Namour F, et al. Diagnosis and pathogenesis of the anaphylactic and anaphylactoid reactions to anaesthetics. Clin Exp Allergy. 1998;28(Suppl 4):65-70.
10. Quiliquini A, Hogendijk S, Hauser C. Anaphylaxis to patent blue. Dermatology. 1998;197:400.
11. Kalimo K, Jansen CT, Kormano M. Sensitivity to patent blue dye during skin-prick testing and lymphography. A retrospective and prospective study. Radiology. 1981;141:365-367.
12. Kalimo K, Saarni H. Immediate reactions to patent blue dye. Contact Dermatitis. 1981;7:171-172.
13. Kopp WL. Anaphylaxis from alphazurine 2G during lymphography. JAMA. 1966;198:668-669.
14. Longnecker SM, Guzzardo MM, Van Voris LP. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharm. 1985;4:219-221.
15. Marshall GD, Lieberman PL. Anaphylactoid reactions to radiocontrast agents. Immunol Allergy Clin North Am. 1998; 18:799-807.
16. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193:473-478.
17. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15: 2345-2350.
18. McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg. 2001;234:292-299; discussion 299-300.
19. Simmons R, Thevarajah S, Brennan MB, et al. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol. 2003;10:242-247.
20. Raut CP, Hunt KK, Kuerer HN. In Reply: blue dye of choice for lymphatic mapping [letter]. J Clin Onc. 2005;23:3648.
21. Perry PM, Meinhard E. Nectotic subcutaneous abscesses following injections of methylene blue. Br J Clin Pract. 1974; 28:289-291.
22. Ruhlen JL. Tissue necrosis. Cutaneous and subcutaneous damage following extravasation of methylene blue. J Kans Med Soc. 1982;83:236, 260.
23. Stradling B, Aranha G, Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg. 2002;184:350-352.
24. Blass N, Fung D. Dyed but not dead-methylene blue overdose. Anesthesiology. 1976;45:458-459.
25. Rainier SS, Quevedo EM, Johnston RV. Dye rashes. Cutis. 1999;63:103-106.
26. Nicolini U, Monni G. Intestinal obstruction in babies exposed in utero to methylene blue. Lancet. 1990;336:1258-1259.
27. Porat R, Gilbert S, Magilner D. Methylene blue-induced phototoxicity: an unrecognized complication. Pediatrics. 1996;97:717-721.
28. van der Pol JG, Wolf H, Boer K, et al. Jejunal atresia related to the use of methylene blue in genetic amniocentesis in twins. Br J Obstet Gynaecol. 1992;99:141-143.
29. Sharr MM, Weller RO, Brice JG. Spinal cord necrosis after intrathecal injection of methylene blue. J Neurol Neurosurg Psychiatry. 1978;41:384-386.
30. Rzymski P, Wozniak J, Opala T, et al. Anaphylactic reaction to methylene blue dye after laparoscopic chromopertubation. Int J Gynaecol Obstet. 2003;81:71-72.
31. Trikha A, Mohan V, Kashyap L, Saxena A. Pulmonary edema following intrauterine methylene blue injection. Acta Anaesthesiol Scand. 1996;40:382-384.
32. Quiney NF, Kissin MW, Tytler I. Anaphylactic reaction to isosulphan blue. Br J Anaesth. 2003;90:105-106.
33. Mullan MH, Deacock SJ, Quiney NF, Kissin MW. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol. 2001;27:218-219.
34. King TA, Fey JV, Van Zee KJ, et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol. 2004;11:535-541.
35. Daley MD, Norman PH, Leak JA, et al. Adverse events associated with the intraoperative injection of isosulfan blue. J Clin Anesth. 2004;16:332-341.